You are here: All Products  > Keymed’s Claudin 18.2 ADC Granted China Breakthrough Status for Gastric Cancer

Keymed’s Claudin 18.2 ADC Granted China Breakthrough Status for Gastric Cancer

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products